MedTrace Logo

Observational Study to Evaluate the Efficacy and Safety of Teneligliptin

NCT03793023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2983

Last updated 2025-01-27

No results posted yet for this study

Summary

This study is designed as a prospective, observational, multi-centre study to evaluate the efficacy and safety of Teneligliptin when switched from other DPP-4 inhibitors in type 2 DM with inadequate glycemic control

Conditions

Interventions

DRUG

Teneligliptin 20mg

Sponsors & Collaborators

  • Handok Inc.

    lead INDUSTRY

Principal Investigators

  • Kwan Woo Lee, MD, Ph.D · Ajou University School of Medicine

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-05
Primary Completion
2019-09-23
Completion
2019-09-23

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793023 on ClinicalTrials.gov